Robin, Alan L., M.D.
Quick facts
Marketed products
- Additional ocular hypotensive medication
- travoprost, latanoprost, or bimatoprost · Ophthalmology
These prostaglandin F (FP) receptor agonists increase uveoscleral outflow of aqueous humor, thereby reducing intraocular pressure.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Robin, Alan L., M.D.
What are Robin, Alan L., M.D.'s marketed drugs?
Top marketed products include Additional ocular hypotensive medication, travoprost, latanoprost, or bimatoprost.
Related
- Additional ocular hypotensive medication
- travoprost, latanoprost, or bimatoprost · Ophthalmology
- Sector hub: All tracked pharma companies